Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H13NO3 |
Molecular Weight | 207.2258 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)NC(CC1=CC=CC=C1)C(O)=O
InChI
InChIKey=CBQJSKKFNMDLON-UHFFFAOYSA-N
InChI=1S/C11H13NO3/c1-8(13)12-10(11(14)15)7-9-5-3-2-4-6-9/h2-6,10H,7H2,1H3,(H,12,13)(H,14,15)
Molecular Formula | C11H13NO3 |
Molecular Weight | 207.2258 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: http://adisinsight.springer.com/drugs/800003808Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7340854
Sources: http://adisinsight.springer.com/drugs/800003808
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7340854
AFALANINE was developed by Medea Research in Italy and licensed to Pulitzer. Phase III clinical trials of MR 708 were completed by Pulitzer. Antidepressant; Antiparkinsonian; Neuroprotectant; Nootropic, Dopamine receptor agonist, was used to treat Major depressive disorder.
CNS Activity
Originator
Sources: http://adisinsight.springer.com/drugs/800003808
Curator's Comment: AFALANINE was developed by Medea Research in Italy and licensed to Pulitzer.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2096905 Sources: http://adisinsight.springer.com/drugs/800003808 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.google.com/patents/CA1144162A?cl=en
Dogs/rats - AFALANINE (MR-708) produced a mild and transienth hypertension when given to narcotized dogs at the dosage rate of 4.5 mg/kg, and to rats narcotized by bilateral vagotomy at the dosage rate of 5 mg/kg
Route of Administration:
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:02:38 GMT 2023
by
admin
on
Fri Dec 15 16:02:38 GMT 2023
|
Record UNII |
FFW2NGO18S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
||
|
NCI_THESAURUS |
C73539
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
21626
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
SUB05280MIG
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
2000
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
C72682
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
43242
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
2901-75-9
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
100000087706
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
FFW2NGO18S
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
DTXSID3045697
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
CHEMBL134570
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
220-793-9
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY | |||
|
6575
Created by
admin on Fri Dec 15 16:02:38 GMT 2023 , Edited by admin on Fri Dec 15 16:02:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |